Spots Global Cancer Trial Database for suramin
Every month we try and update this database with for suramin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
Suramin in Treating Patients With Recurrent Bladder Cancer | NCT00006476 | Bladder Cancer | suramin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer | NCT01671332 | Carcinoma, Non ... | Docetaxel Suramin Docetaxel | 18 Years - | University of Wisconsin, Madison | |
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | NCT00001266 | Prostatic Neopl... | Suramin | - | National Institutes of Health Clinical Center (CC) | |
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer | NCT00066768 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | suramin docetaxel gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00004073 | Brain and Centr... | suramin radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery | NCT00002921 | Adrenocortical ... | suramin therapeutic hyd... | 18 Years - | SWOG Cancer Research Network | |
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer | NCT01038752 | Non-small Cell ... | Suramin Drug:Do... Placebo Drug: D... | 18 Years - | Optimum Therapeutics, LLC | |
Suramin in Treating Patients With Recurrent Primary Brain Tumors | NCT00002639 | Brain and Centr... | chemotherapy suramin | 15 Years - | National Cancer Institute (NCI) | |
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease | NCT00002652 | Multiple Myelom... | suramin | 18 Years - | National Cancer Institute (NCI) | |
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00006929 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | suramin carboplatin paclitaxel pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | NCT00002881 | Prostate Cancer | flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy | 18 Years - | National Cancer Institute (NCI) | |
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer | NCT00002723 | Prostate Cancer | suramin suramin Suramin | 18 Years - | National Cancer Institute (NCI) | |
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer | NCT00054028 | Recurrent Breas... Stage IIIB Brea... Stage IV Breast... | suramin paclitaxel pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00006929 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | suramin carboplatin paclitaxel pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | NCT00002881 | Prostate Cancer | flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy | 18 Years - | National Cancer Institute (NCI) | |
Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | NCT00083109 | Recurrent Renal... Stage IV Renal ... | Fluorouracil Pharmacological... Suramin | 18 Years - | National Cancer Institute (NCI) |